Home > Loeb & Loeb LLP > Legal Library

Legal Articles: Loeb & Loeb LLP

 







Document(s) published by this organization: 91


View Page: 1  2  3  4  5  6  7  8  9  10  Next  
Show: results per page
Sort by:

HTMLDigital Advertising Alliance Announces New Mobile Opt-Out Tools
Kenneth R. Florin, Ieuan Jolly, James D. Taylor; Loeb & Loeb LLP;
Legal Alert/Article
April 15, 2015, previously published on March 2015
The Digital Advertising Alliance (DAA) announced two new mechanisms that will allow consumers to manage ad preferences on their mobile devices. The tools are intended to complement the existing opt-out mechanisms that are part of the DAA's self-regulatory program for online targeted advertising and...

 

HTMLAn Introductory Guide to Rev 973 v. Mouren-Laurens Et Al
Albert M. Cohen; Loeb & Loeb LLP;
Legal Alert/Article
March 20, 2015, previously published on March 2015
Loeb & Loeb LLP represents a group of approximately 45 potentially responsible parties (PRPs) in the Rev 973 litigation, though the number is constantly changing as additional parties join the group. The following is an introduction to the case and a summary of its current posture. If you have...

 

HTMLFY 2016 Budget Request Reflects FDA’s Broadening Scope of Activities
Scott S. Liebman; Loeb & Loeb LLP;
Legal Alert/Article
March 18, 2015, previously published on February 2015
The regulator’s requested budget of $4.9 billion for the upcoming fiscal year represents a 9% increase from the enacted FY 2015 budget, with $147.7 million allocated for initiatives associated with what it calls “key areas,” including improving the safety and quality of medical...

 

HTMLDraft Documents On Drug Compounding And Repackaging Issued By the FDA Help Entities Comply With Public Health Provisions
Scott S. Liebman; Loeb & Loeb LLP;
Legal Alert/Article
March 18, 2015, previously published on February 2015
The regulator published five draft documents as part of a larger series of policy documents concerning the FDA’s oversight of drugs produced by state-licensed pharmacies, federal facilities and outsourcing facilities.

 

HTMLWhite House Releases Draft Privacy Bill
Kenneth R. Florin, Ieuan Jolly, James D. Taylor; Loeb & Loeb LLP;
Legal Alert/Article
March 18, 2015, previously published on March 2015
The White House released a discussion draft of the Consumer Privacy Bill of Rights Act of 2015. The Act is intended to establish baseline privacy protections for individuals in industries which are not currently regulated at the federal level, and to provide a process for the development and...

 

HTMLFDA Advises Pharma Companies to Simplify Consumer Print Ads, Hopes New Approach Will Resonate Better With Patients
Scott S. Liebman; Loeb & Loeb LLP;
Legal Alert/Article
March 18, 2015, previously published on February 2015
The FDA is recommending that drug companies aim for comprehension with their consumer-directed print ads by limiting the risk information, more fully integrating it via text and visual cues, and by using more consumer-friendly language.

 

HTMLBeware of Citizen Suits for Storm Water Violations
Albert M. Cohen; Loeb & Loeb LLP;
Legal Alert/Article
February 26, 2015, previously published on February 2015
In recent months several private organizations have sent letters to California businesses informing them that they are in violation of their storm water permits and threatening to sue them under the citizen suit provision of the Clean Water Act, which authorizes private parties to enforce...

 

HTMLBeastie Boys v. Monster Energy Company
Tal Dickstein, W. Allan Edmiston, David A. Grossman, Jonathan Neil Strauss, Jonathan Zavin; Loeb & Loeb LLP;
Legal Alert/Article
February 25, 2015, previously published on December 4, 2014
Following jury verdict in favor of Beastie Boys on copyright infringement and Lanham Act claims, district court denies defendant Monster Energy Company’s motions for judgment as matter of law, for new trial, and for reduction in damages, finding that trial evidence supported jury’s...

 

HTMLIn An Unusual Move, The FDA Takes Issue With The Accuracy Of Sciecure’s Studies In A Warning Letter Over Sales Promotion Material For The Company’s Sleeping Pill
Scott S. Liebman; Loeb & Loeb LLP;
Legal Alert/Article
February 25, 2015, previously published on November 2014
In addition to criticizing the pharmaceutical company for leaving out risk information from its sales materials and making unsupported superiority claims, the regulator unusually disputed the accuracy of the sources Sciecure used to bolster its assertions.

 

HTMLFDA Proposes Three Studies on Direct-To-Consumer Prescription Drug Ads in a Bid to Better Understand the Impact of Ad Exposure Frequency, Spousal Influence and Risk Understanding
Scott S. Liebman; Loeb & Loeb LLP;
Legal Alert/Article
February 25, 2015, previously published on November 2014
The agency announced three proposed studies on how people view direct-to-consumer advertising, as it continues to assess factors that influence assessments of risks and benefits in a bid to ensure its regulations adequately protect public health.

 


View Page: 1  2  3  4  5  6  7  8  9  10  Next